Navigation Links
UCB Announces Positive Top-Line Phase III Results for Keppra as,Adjunctive Therapy for Partial Onset Seizures in Paediatric,Patients from One Month to Less than Four Years of Age

86 [3] U.S. Prescribing Information Keppra® tablets and oral solution (24E) (available at www.Keppra.com). [4] U.S. Prescribing Information Keppra® injection (2E) (available at www.Keppra.com). [5] Keppra® Summary of Product Characteristics, January 2007 (available at www.emea.eu.int).


'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:10/10/2008)..., Oct. 10 /- Boston Scienti...schedule of the Company,s major,events and press a...tion,s,(CRF) twentieth annual Transcatheter Cardio...which runs from October 12 to 17 in Washington, D....ange of safety and,efficacy data on its TAXUS(R) E...
(Date:10/9/2008)...s for Increased Sales and Marketing Efforts to Acc...ip(R) System, MENLO PARK, Calif., Oct. 9 /PRNewsw...t of devices for the percutaneous repair of cardia...cutive team with the appointment of,Sean Cleary as...eting and,Chris Richardson, as vice president of s...
(Date:10/8/2008)...a., Oct. 8 /PRNewswire-USNewswire/ -- The facts ar... from HIV/AIDS in,sub-Saharan Africa. More than 35...frica have already died of AIDS. The Foundation fo...ure the dying and their families,find compassion a...,s,innovative partnering initiative links African ...
(Date:10/8/2008)...ab Program to be Discontinued and Headcount to be ...its Portfolio Review; Zanolimumab Program to be D... of Employees, COPE... A/S (OMX: GEN),announced today that it is discont...In addition, as a result of a portfolio review and...
Breaking Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Evalve Expands Executive Leadership Team 2Evalve Expands Executive Leadership Team 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 1The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 2The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 3The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 4The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 5The 7 Key Questions About the Schwarzenegger Nunez Health Care Compromise 620 6New knock out gene model provides molecular clues to breast cancer 615 1New knock out gene model provides molecular clues to breast cancer 615 2New knock out gene model provides molecular clues to breast cancer 615 3Martek Announces Third Quarter 2007 Financial Results 613 1Martek Announces Third Quarter 2007 Financial Results 613 2Martek Announces Third Quarter 2007 Financial Results 613 3Martek Announces Third Quarter 2007 Financial Results 613 4Martek Announces Third Quarter 2007 Financial Results 613 5Martek Announces Third Quarter 2007 Financial Results 613 6Martek Announces Third Quarter 2007 Financial Results 613 7Martek Announces Third Quarter 2007 Financial Results 613 8Martek Announces Third Quarter 2007 Financial Results 613 9Martek Announces Third Quarter 2007 Financial Results 613 10Martek Announces Third Quarter 2007 Financial Results 613 11Martek Announces Third Quarter 2007 Financial Results 613 12IRIDEX Announces Closing of 245 0 Million Private Placement 608 1IRIDEX Announces Closing of 245 0 Million Private Placement 608 2IRIDEX Announces Closing of 245 0 Million Private Placement 608 3IRIDEX Announces Closing of 245 0 Million Private Placement 608 4
...TTLE--(BUSINESS WIRE)--Apr 19, 2007 - Gilead Scien...esults of its Phase III,AIR-CF2 study evaluating a...patients with cystic fibrosis (CF) who have,pulmon... study, a,28-day treatment course of aztreonam lys...haled or intravenous (IV) antibiotics versus,place...
...VER--(BUSINESS WIRE)--Apr 23, 2007 - Ceragenix Pha...al company focused on,infectious disease and derma...rch paper on two of the Company,s antimicrobial,co...he April issue,of the Journal of Antimicrobial Age...rnal of the American Society of,Microbiology, dedi...
Other Medicine Technology:Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 2Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 3Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 4Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 5Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 6Gilead Announces Presentation of Positive Phase III Data on,Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis 7Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 2Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 3Ceragenix Announces New Publication of Scientific Research on,Ceragenin Technology 4
(Date:10/13/2008)...eading Content Rights Management System, Supports... Content Spend, WEST CHESTER, Pa., Oct. 13 /PRNew...ding global pharmaceutical manufacturer has integr...primary platform for the,secure distribution, data...cs for their new product video content. Imperium i...
(Date:10/13/2008)...swire/ -- The National Coalition for,Quality Color...ncerns over,the National CT Colonography Study pub...Medicine. The evidence must be closely evaluated, ...y is not without significant,potential risks. The ...py,remains the "Gold Standard" for colorectal canc...
(Date:10/13/2008)...blem in daily life, survey shows, PORTLAND, Ore.,...three-quarters of people living with psoriasis say...e, according to a National Psoriasis,Foundation 20...viduals with psoriasis and psoriatic arthritis,als...ly lives, shapes their,feelings about themselves a...
(Date:10/13/2008)...swire/ -- During the Pri-Med New York,conference a...are providers,took a 20-question quiz prepared by ...n Somerset, NJ. The quiz tested basic knowledge of..., EMR software, and healthcare,administration., T... The average number,of correct answers was only 7....
Breaking Medicine News(10 mins):Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 2Health News:National Coalition for Quality Colorectal Cancer Screening and Care Conveys Concerns over CT Colonography 3Health News:National Psoriasis Foundation Releases 2008 Study Results 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2
...000 worth of unapproved dietary supplements in the...e Food and Drug Administration (FDA) agency had re...age Nutraceuticals L.L.C distributed the capsules....at the seized capsules, which are supposedly in vi...
...reast cancer cases in American women appears to ha.../ that a turning point may have reached in the nat...e latest federal data it was found that after a st...cer rate stopped rising in 2001 and may have start...
...ly poetic way to describe a disease that is the fu...s father’s life and, Galvin always knew, threatene...’s sitting out on the horizon that you know one da...ays Galvin, 37. “It’s something I’ve thought about...
...d of the conjoined twins from Wisconsin has been c...ork remains ahead of them.// The lead surgeon, Ro... optimistic about the preservation of neurological...ave decided not to separate the twins' shared tail...
Other Medicine News:Health News:Plateau Reached in the Battle against Breast Cancer 2Health News:Plateau Reached in the Battle against Breast Cancer 3Health News:Deadly Lung Disease Sends Patients on ‘Quest for Breath 2Health News:Deadly Lung Disease Sends Patients on ‘Quest for Breath 3Health News:Separation of Spinal Cord of Conjoined Twins Completed Successfully 2
Gentamicin Reagent Solution (10 mg/ml) liquid
LB Agar plates with 0.1mM EDTA.
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride.
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride.
Medicine Products: